Johns Hopkins study shows potential for chemical vaccine against malaria
Malaria was responsible for over 600,000 worldwide deaths in 2021
Read More
Tag: Johns Hopkins Malaria Research Institute
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
